Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FMXJP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,555
Award facts
- Contract value 100% obligated
- $25,555.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,555.12 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion master vehicle that extends through December 2026. The delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the broad pharmaceutical portfolio that AmerisourceBergen supplies to support military and federal healthcare programs.
As a major pharmaceutical distributor and critical vendor within the federal medical procurement system, AmerisourceBergen Drug Corp serves defense and civilian healthcare systems with an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The Pharmaceutical Prime Vendor Global Program vehicle under which this order was issued enables the company to provide comprehensive pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. No set-aside designation was applied to this award, confirming its competitive nature consistent with AmerisourceBergen's historical contract performance with the DLA.
Quick answers
Who was awarded contract SPE2DB25FMXJP?
SPE2DB25FMXJP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FMXJP worth?
The government has obligated $25,555 on SPE2DB25FMXJP.
Is contract SPE2DB25FMXJP an order under another contract?
Yes. SPE2DB25FMXJP is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMXJP competed?
The extent of competition for SPE2DB25FMXJP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award